Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Emrah Eraslan"'
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Ahmet Özet, Aytuğ Üner, Nazan Günel, Ozan Yazıcı, Gözde Savaş, Ahmet Bayrak, Emrah Eraslan, Berna Öksüzoğlu, Hüseyin Koray Kılıç, Nuriye Özdemir
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Introduction Resistance to immune checkpoint inhibitors (ICI) is a significant issue in metastatic renal cell carcinoma (mRCC), as it is in the majority of cancer types. An important deficiency in immunooncology today is the lack of a predic
Externí odkaz:
https://doaj.org/article/064c7efbc4eb4b068e1b246c055dc512
Publikováno v:
Journal of Oncological Sciences, Vol 5, Iss 1, Pp 1-5 (2019)
Background: Advanced pancreatic cancer (APC) is a highly lethal malignancy which has one of the worst treatment outcomes. Modified (m)FOLFIRINOX is an intense but a proven treatment approach with a survival benefit for APC. Although mFOLFIRINOX demon
Externí odkaz:
https://doaj.org/article/01aad66df48e426f93b4805fc988968f
Autor:
Aysegul İlhan, Fatih Gurler, Funda Yilmaz, Erdogan Seyran, Vural Bastug, Bugra Gorgulu, Emrah Eraslan, Özgen Ahmet Yıldırım, Ozan Yazici, Ömür Berna Çakmak Öksüzoğlu
Publikováno v:
Cureus.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6e9102a165959e29d2e9a81018720941
https://doi.org/10.7759/cureus.35710
https://doi.org/10.7759/cureus.35710
Autor:
Ahmet Bilici, Sinan Koca, Mustafa Karaagac, Sabin Goktas Aydin, Emrah Eraslan, Muhammed Ali Kaplan, Birol Ocak, Sema Sezgin Goksu, Semra Paydas, Fahri Akgul, Sumeyye Derin, Yakup Ergun, Emre Yekeduz, Cihan Erol, Deniz Tataroglu Ozyukseler, Atike Gokcen Demiray, Mustafa Karaca, Zeynep Gulsum Guc, Serkan Menekse, Havva Yesil Cinkir, Ozge Gumusay, Abdullah Sakin, Ozlem Ozkul, Hacer Demir, Dilek Erdem, Mehmet Besiroglu, Olcun Umit Unal, Ramazan Acar, Lokman Koral, Suleyman Sahin, Teoman Sakalar, Aykut Bahceci, Ahmet Ozveren, Ulug Mutlu Gunaydin, Mehmet Metin Seker, Veli Sunar, Pinar Dal, Mehmet Artac, Serdar Turhal
Aim: Description of patient characteristics, effectiveness and safety in Turkish patients treated with pazopanib for metastatic soft tissue sarcoma (STS). Patients and methods: This multicenter study is based on retrospective review of hospital medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e475dde06decc907f161d14d4d0f2ae4
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
https://avesis.deu.edu.tr/publication/details/c895112d-5502-4614-a59b-a819d23aebc3/oai
Publikováno v:
Volume: 4, Issue: 6 795-799
Journal of Health Sciences and Medicine
Journal of Health Sciences and Medicine
Aim: To evaluate whether obtaining a clinical benefit with first-line therapy in patients receiving palliative systemic therapy with a diagnosis of metastatic uterine leiomyosarcoma (ULMS) provides a survival benefit and the factors that may predict
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8c5d62e4622e6ae1159da7e35c26428
https://doi.org/10.32322/jhsm.963151
https://doi.org/10.32322/jhsm.963151
Autor:
Emrah Eraslan, Mutlu Dogan
Publikováno v:
Medical Science and Discovery. 8:283-288
Objective: Inflammatory markers have prognostic significance for renal cell carcinomas (RCC) as in many types of cancer. The prognostic effect of inflammatory markers in the rare histological subtypes of RCC has not been adequately evaluated. In our
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e5575b1e362ca5913fbbd2437820666a
https://doi.org/10.36472/msd.v8i4.535
https://doi.org/10.36472/msd.v8i4.535
Publikováno v:
Cureus. 14(3)
Objective In this study, we aimed to examine the effect of post-traumatic growth and depressive symptoms on caregiver burden in caregivers of cancer patients. Methods This was a single-center cross-sectional observational descriptive study conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4623a0e9fa7d4f4a39d394b12188ddd
https://pubmed.ncbi.nlm.nih.gov/35494993
https://pubmed.ncbi.nlm.nih.gov/35494993
Autor:
Ülkü Yalçintaş, Emrah Eraslan
Publikováno v:
Journal of Surgery and Medicine, Vol 4, Iss 9, Pp 803-807 (2020)
Aim: Sarcomatoid renal cell cancer (sRCC) is an extremely rare condition, and literature on disease management is limited. There are no treatment recommendations based on high-quality data. Our aim in this study is to reveal our long-term experience
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb39759cc78fc9e979a54f4b41da7d37
https://doi.org/10.28982/josam.789516
https://doi.org/10.28982/josam.789516
Autor:
Dogan Uncu, Gokhan Ucar, Deniz Can Guven, Deniz Tural, Nazan Günel, Ozan Yazıcı, Nuriye Ozdemir, Aytug Uner, Osman Sütcüoğlu, Omur Berna Oksuzoglu, Seher Yildiz Tacar, Saadettin Kilickap, Aysegul Ilhan, Ahmet Ozet, Fatih Yildiz, Emrah Eraslan, Nuri Karadurmus
Publikováno v:
Immunotherapy. 13(17)
Background: The aim of this study was to determine the cause of death in patients who died within 30 days after the first dose of immunotherapy. Methods: The data of 1432 patients treated with immunotherapy in six tertiary referral hospitals were ret
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c36977f997360d832152fa7093fb35c6
https://pubmed.ncbi.nlm.nih.gov/34676791
https://pubmed.ncbi.nlm.nih.gov/34676791
Autor:
Volkan Aslan, Atiye Cenay Karabörk Kılıç, Osman Sütcüoğlu, Emrah Eraslan, Ahmet Bayrak, Berna Öksüzoğlu, Gözde Tahtacı, Nuriye Özdemir, Aytuğ Üner, Nazan Günel, Ahmet Özet, Ozan Yazıcı
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 40:494.e1-494.e10
Immune checkpoint inhibitors (ICI) have transformed treatments for patients with metastatic renal cell carcinoma (mRCC). Although some patients benefit greatly from ICI treatments, an effective marker to determine which patients will benefit from the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa533669458a77ef0525ac268e0a8e22
https://doi.org/10.1016/j.urolonc.2022.07.018
https://doi.org/10.1016/j.urolonc.2022.07.018